Opportunities Preloader

Please Wait.....

Report

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

Market Research Report I 2024-07-16 I 110 Pages I BCC Research

Description

Report Scope:

This report covers the worldwide market for SNP genotyping, with the market segmented by technology and application. It provides an in-depth analysis of the SNP genotyping market, including estimates and trends through 2029. In this report, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029. This report also uses analytical frameworks such as PESTEL, examines the competitive landscape, and explores trends in ESG and funding.

Report Includes:

- 37 data tables and 44 additional tables
- An overview of the global market for single nucleotide polymorphism (SNP) genotyping
- Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Evaluation of the current market size and revenue growth prospects specific to SNP genotyping, along with a market share analysis by technology, application, and region
- Discussion of the advantages of the most frequently used SNP genotyping techniques, such as Sequenom's MassArray DNA analysis platform, Bruker's MALDI-TOF array, SNP pyrosequencing, microarrays and gene chips, and Applied Biosystems' (now part of Thermo Fisher Scientific) SNPlex and TaqMan
- Analysis of the regulatory framework and policies affecting the industry
- Discussion of the ESG practices of, as well as challenges for, companies
- Analysis of the key companies' market shares and their proprietary technologies, strategic alliances and patents
- Company profiles of the leading players, including Agilent Technologies Inc., F. Hoffman-La Roche Ltd., Illumina Inc., Qiagen, and Thermo Fisher Scientific Inc.

Executive Summary

Summary:

Single nucleotide polymorphism (SNP) genotyping is a form of genotyping used to measure genetic variation. SNP, the most widely used form of genotyping, increases our understanding of the correlations between genotype and behavior exhibited by a living organism. SNP genotyping is generally used as a tool for identifying genomic variations and can lead to the determination of the health and ancestry of animals and plants. Increasing applications of SNPs in many areas is driving the market. However, diagnostics and pharmacogenomics represent the most attractive application areas for SNP genotyping. For SNP genotyping, several commercial platforms and methods have been developed.

SNPs cause phenotypic variations, influence the onset and course of many illnesses, and control how a gene reacts to medication and environmental stress. SNPs can also be molecular markers for determining the genes linked to significant biological traits and illnesses. Therefore, SNP profiling is important for pharmacological treatment, personalized medicine, agricultural productivity, and selective breeding. Alteration of a single nucleotide (A, T, C or G) in the genome sequence creates variations in the DNA sequence. A person's unique DNA pattern combines several SNPs. The ability to grasp and treat human sickness is advanced by SNPs, the most general genome mutations among all living things. SNP genotyping is the most prominent segment of the market and is inherent to genomics.

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
SNP for Mutational Analysis
SNP Definition
Methods of Studying SNPs
Classification of SNPs
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Declining Prices of DNA Sequencing Methods
Demand for Personalized Treatments
Personalized Medicine and SNP Genotyping in the Drug Development Process
Increasing Demand for Genome Analysis in Plants and Animal Livestock
Market Restraints
Reimbursement Policies
Market Opportunities
Increasing Applications of SNP Genotyping
Rising Investments in Genomics Research
Chapter 4 Emerging Technologies and Developments
SNP-Chip
SNP Genotyping Technologies in Forensic Science
Artificial Intelligence in SNP Genotyping
Chapter 5 Market Segmentation Analysis
Market Trends
Segmentation Breakdown
Global Market for SNP Genotyping, by Technology
Microarrays and GeneChips
SNP Pyrosequencing
TaqMan Allelic Discrimination
Applied Biosystems SNPlex Platform
MassArray Maldi-TOF
Other SNP Genotyping Technologies
Global Market for SNP Genotyping, by Application
Pharmaceuticals and Pharmacogenomics
Diagnostic Research
Agricultural Biotechnology
Animal Genetics
Plant Improvements
Aquaculture
Other Applications
Geographic Breakdown
Global Market for SNP Genotyping, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Funding
Leading Companies
Key Strategies Adopted by Players
Partnerships
Other Strategies
Chapter 7 Sustainability in the SNP Genotyping Market: An ESG Perspective
ESG Performance in the Market
ESG Practices in the SNP Genotyping Industry
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks from BCC Research
Chapter 8 Appendix
Methodology
Acronyms
References
Company Profiles
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
CYTIVA
ENZO BIOCHEM INC.
EPIGENDX
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
QIAGEN
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.

List of Tables
Summary Table : Global Market for SNP Genotyping, by Region, Through 2029
Table 1 : SNP Public Databases
Table 2 : Role of SNP Genotyping in Stages of the Drug Development Process
Table 3 : Global Market for SNP Genotyping, by Technology, Through 2029
Table 4 : Global Market for Microarrays and GeneChips in SNP Genotyping, by Region, Through 2029
Table 5 : Global Market for Pyrosequencing in SNP Genotyping, by Region, Through 2029
Table 6 : Global Market for TaqMan Allelic Discrimination in SNP Genotyping, by Region, Through 2029
Table 7 : Global Market for Applied Biosystems SNPlex Platform in SNP Genotyping, by Region, Through 2029
Table 8 : Global Market for MassArray Maldi-TOF in SNP Genotyping, by Region, Through 2029
Table 9 : Global Market for Other Technologies in SNP Genotyping, by Region, Through 2029
Table 10 : Global Market for SNP Genotyping, by Application, Through 2029
Table 11 : Global Market for Pharmaceuticals and Pharmacogenomics Applications in SNP Genotyping, by Region, Through 2029
Table 12 : Global Market for Diagnostic Research Applications in SNP Genotyping, by Region, Through 2029
Table 13 : Global Market for Agricultural Biotechnology Applications in SNP Genotyping, by Region, Through 2029
Table 14 : Global Market for Animal Genetics Applications in SNP Genotyping, by Region, Through 2029
Table 15 : Global Market for Plant Improvement Applications in SNP Genotyping, by Region, Through 2029
Table 16 : Global Market for Aquaculture Applications in SNP Genotyping, by Region, Through 2029
Table 17 : Global Market for Other Applications in SNP Genotyping, by Region, Through 2029
Table 18 : Global Market for SNP Genotyping, by Region, Through 2029
Table 19 : North American Market for SNP Genotyping, by Technology, Through 2029
Table 20 : North American Market for SNP Genotyping, by Application, Through 2029
Table 21 : National Genome Projects in Europe
Table 22 : European Market for SNP Genotyping, by Technology, Through 2029
Table 23 : European Market for SNP Genotyping, by Application, Through 2029
Table 24 : Asia-Pacific Market for SNP Genotyping, by Technology, Through 2029
Table 25 : Asia-Pacific Market for SNP Genotyping, by Application, Through 2029
Table 26 : RoW Market for SNP Genotyping, by Technology, Through 2029
Table 27 : RoW Market for SNP Genotyping, by Application, Through 2029
Table 28 : Major Private and Public Funding Organizations
Table 29 : National Human Genome Research Institute, NIH Funded and Completed Projects
Table 30 : Leaders in the SNP Genotyping Market, 2023
Table 31 : Business Expansions in the Global SNP Genotyping Market, 2021-2024
Table 32 : Product Launches in the Global SNP Genotyping Market, 2021-2024
Table 33 : Collaborations and Agreements in the Global SNP Genotyping Market, 2022 and 2023
Table 34 : Partnerships in the Global SNP Genotyping Market, 2021-2024
Table 35 : Other Business Strategies Adopted by Key Players in SNP Genotyping Market, 2021-2024
Table 36 : Key Focus Areas in ESG Metrics
Table 37 : Environmental Performance Initiatives in the SNP Genotyping Market
Table 38 : Social Performance Initiatives in the SNP Genotyping Market
Table 39 : Governance Performance Initiatives in the SNP Genotyping Market
Table 40 : ESG Rankings for SNP Genotyping Companies, 2023*
Table 41 : Abbreviations Used in This Report
Table 42 : Agilent Technologies Inc.: Company Snapshot
Table 43 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 44 : Agilent Technologies Inc.: Product Portfolio
Table 45 : Agilent Technologies Inc.: News/Key Developments, 2021-2023
Table 46 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
Table 47 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
Table 48 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2021-2023
Table 49 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 50 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 51 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 52 : Cytiva: Company Snapshot
Table 53 : Cytiva: Product Portfolio
Table 54 : Cytiva: News/Key Developments, 2023
Table 55 : Enzo Biochem Inc.: Company Snapshot
Table 56 : Enzo Biochem Inc.: Financial Performance, FY 2022 and 2023
Table 57 : Enzo Biochem Inc.: Product Portfolio
Table 58 : Enzo Biochem Inc.: News/Key Developments, 2022
Table 59 : EpigenDx.: Company Snapshot
Table 60 : EpigenDx: Service Portfolio
Table 61 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 62 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 63 : F. Hoffman-La Roche Ltd.: Product Portfolio
Table 64 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2021
Table 65 : Illumina Inc.: Company Snapshot
Table 66 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 67 : Illumina Inc.: Services Portfolio
Table 68 : Illumina Inc.: News/Key Developments, 2022 and 2023
Table 69 : Qiagen: Company Snapshot
Table 70 : Qiagen: Financial Performance, FY 2022 and 2023
Table 71 : Qiagen: Product Portfolio
Table 72 : Qiagen: News/Key Developments, 2023 and 2024
Table 73 : Standard BioTools: Company Snapshot
Table 74 : Standard BioTools: Financial Performance, FY 2022 and 2023
Table 75 : Standard BioTools: Product Portfolio
Table 76 : Standard BioTools: News/Key Developments, 2022 and 2023
Table 77 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 78 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 79 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 80 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024

List of Figures
Summary Figure : Global Market for SNP Genotyping, by Region, 2021-2029
Figure 1 : Classification of SNPs
Figure 2 : PESTEL Analysis: SNP Genotyping Market
Figure 3 : Market Dynamics of SNP Genotyping
Figure 4 : Average Cost Per Genome: Y-o-Y Trend, 2011-2022
Figure 5 : Snapshot of SNP Genotyping Market: Business Strategies
Figure 6 : Global Market Share for SNP Genotyping, by Technology, 2024
Figure 7 : Global Market for Microarrays and GeneChips in SNP Genotyping, by Region, 2021-2029
Figure 8 : Global Market for Pyrosequencing in SNP Genotyping, by Region, 2021-2029
Figure 9 : Global Market for TaqMan Allelic Discrimination in SNP Genotyping, by Region, 2021-2029
Figure 10 : Global Market for Applied Biosystems SNPlex in SNP Genotyping, by Region, 2021-2029
Figure 11 : Global Market for MassArray Maldi-TOF in SNP Genotyping, by Region, 2021-2029
Figure 12 : Global Market for Other Technologies in SNP Genotyping, by Region, 2021-2029
Figure 13 : Global Market Share for SNP Genotyping, by Application, 2024
Figure 14 : Global Market for Pharmaceuticals and Pharmacogenomics Applications in SNP Genotyping, by Region, 2021-2029
Figure 15 : Global Market for Diagnostic Research Applications in SNP Genotyping, by Region, 2021-2029
Figure 16 : Major Applications of SNP Genotyping in Agricultural Biotechnology
Figure 17 : Global Market for Agricultural Biotechnology Applications in SNP Genotyping, by Region, 2021-2029
Figure 18 : Applications of SNP Genotyping in Animal Genetics
Figure 19 : Global Market for Animal Genetics Applications in SNP Genotyping, by Region, 2021-2029
Figure 20 : Global Market for Plant Improvement Applications in SNP Genotyping, by Region, 2021-2029
Figure 21 : Global Market for Aquaculture Applications in SNP Genotyping, by Region, 2021-2029
Figure 22 : Global Market for Other Applications in SNP Genotyping, by Region, 2021-2029
Figure 23 : Global Market Share for SNP Genotyping, by Region, 2024
Figure 24 : Share of New Genetic Tests in the U.S., by CLIA-certified Laboratory, 2012 to 2022
Figure 25 : North American Market for SNP Genotyping, by Technology, 2021-2029
Figure 26 : North American Market for SNP Genotyping, by Application, 2021-2029
Figure 27 : European Market for SNP Genotyping, by Technology, 2021-2029
Figure 28 : European Market for SNP Genotyping, by Application, 2021-2029
Figure 29 : Drivers of the Asia-Pacific Market for SNP Genotyping
Figure 30 : Asia-Pacific Market for SNP Genotyping, by Technology, 2021-2029
Figure 31 : Asia-Pacific Market for SNP Genotyping, by Application, 2021-2029
Figure 32 : RoW Market for SNP Genotyping, by Technology, 2021-2029
Figure 33 : RoW Market for SNP Genotyping, by Application, 2021-2029
Figure 34 : Share of the Global SNP Genotyping Market, Competitive Intelligence, by Strategy, 2021-2024
Figure 35 : How a Strong ESG Proposition Benefits Businesses
Figure 36 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 37 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 38 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 39 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 40 : Enzo Biochem Inc.: Revenue Share, by Country/Region, FY 2023
Figure 41 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 43 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 44 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 45 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 46 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 47 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 48 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 49 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 50 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $5500.00
  • $6600.00
  • $7920.00
  • $9504.00
  • ADD TO BASKET
  • BUY NOW